Advertisement

International Ophthalmology

, Volume 37, Issue 1, pp 303–312 | Cite as

Demodex species in human ocular disease: new clinicopathological aspects

  • Stephen G. Nicholls
  • Carmen L. OakleyEmail author
  • Andrea Tan
  • Brendan J. Vote
Review

Abstract

Demodex brevis and Demodex folliculorum are likely ubiquitous organisms associated with human eyelashes. However, they have also been implicated in the pathogenesis of external ocular diseases. This article reviews the current literature in regards to life cycle, morphology, pathogenesis and treatment of underlying Demodex spp. infestation and outlines the previously undescribed in vivo behaviour of the mites. Images were obtained from the epilation of lashes from 404 patients seen in clinical practice. Epilated lashes were placed on a microscope slide which had been coated with optically clear hypromellose/carbomer gel (Genteal gel, Novartis pharmaceuticals corporation, East Hanover, New Jersey). Adults were identified with either dark field or standard transmission microscopy at 40–100×. Eggs and other life-cycle stages were examined at 250× magnification, with transmission microscopy giving the best image resolution. The life cycle of the mite has been reviewed and simplified according to clinical observations. Clinical signs suggestive of underlying Demodex spp. infestation have been described, and their pathogenesis was explained based on the micrographic digital images obtained. The problem of symptomatic Demodex spp. disease likely reflects an imbalance in the external ocular ecology; however, the role of Demodex spp. as a commensal should not be overlooked. Treatment should not be aimed at total eradication of the mite but rather restoring the ocular ecology to a balanced state. By revisiting the life cycle of the mite, we can identify areas where possible intervention may be effective.

Keywords

Demodex External ocular disease Dry eye disease Blepharitis 

Notes

Author Contributions

SGN was involved in study design, acquisition of data, analysis of data, manuscript preparation and final approval of manuscript. CLO was involved in data analysis, literature review, manuscript preparation and final approval of manuscript. AT was involved in data analysis, literature review and final approval of manuscript. BJV was involved in data analysis, manuscript preparation and final approval of manuscript.

Compliance with ethical standards

Conflict of interest

There are no competing interests to declare in regards to this research, from any author.

References

  1. 1.
    Lacey N, Ni Raghallaigh S, Powell FC (2011) Demodex mites: commensals, parasites or mutualistic organisms. Dermatology 222:128–130CrossRefPubMedGoogle Scholar
  2. 2.
    Lacey N, Kavanagh K, Tseng SCG (2009) Under the lash: demodex mites in human diseases. Biochemist 31(4):2–6PubMedPubMedCentralGoogle Scholar
  3. 3.
    Lee SH, Chun YS, Kim JH et al (2010) The relationship between Demodex and ocular discomfort. Invest Ophthalmol Vis Sci 51(6):2906–2911CrossRefPubMedGoogle Scholar
  4. 4.
    Kim JH, Chun YS, Kim JC (2011) Clinical and Immunological Responses in Ocular Demodecosis. J Korean Med Sci 26(9):1231–1237CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Thoemmes MS, Fergus DJ, Urban J et al (2014) Ubiquity and diversity of human-associated Demodex mites. PLoS One. doi: 10.1371/journal.pone.0106265 PubMedPubMedCentralGoogle Scholar
  6. 6.
    Hsu CK, Hsu MM, Lee JY (2007) Demodicosis: a clinicopathological study. J Am Acad Dermatol 60(3):453–462CrossRefGoogle Scholar
  7. 7.
    Mastrota KM (2013) Method to identify Demodex in the eyelash follicle without epilation. Optom Vis Sci 90(6):172–174CrossRefGoogle Scholar
  8. 8.
    Kheirkhah A, Blanco G, Casas V et al (2007) Fluorescein dye improves microscopic evaluation and counting of demodex in blepharitis with cylindrical dandruff. Cornea 26(6):697–700CrossRefPubMedGoogle Scholar
  9. 9.
    English FP (1971) Variant of Demodex folliculorum infesting the eyelids. Brit J Ophthal 55(11):747–749CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Farrant S (2014) Demodex: at the root of the problem, OtCET http://www.optometry.co.uk/uploads/articles/cet-2014/cet_2_aug_1_c-37163__demodex_at_the_root_of_the_problem%281%29.pdf. Accessed July 2015
  11. 11.
    Szkaradkiewicz A, Chudzicka-Strugała I, Karpiński TM et al (2012) Bacillus oleronius and Demodex mite infestation in patients with chronic blepharitits. Clin Microbiol Infect 18(10):1020–1025CrossRefPubMedGoogle Scholar
  12. 12.
    Spickett SG (1961) Studies on Demodex folliculorum Simon (1842). I. Life History. Parasitology 51:181–192CrossRefGoogle Scholar
  13. 13.
    Rufli T, Mumcuoglu Y (1981) The hair follicle mites Demodex folliculorum and Demodex brevis: biology and medical importance: a review. Dermatologica 162:1–11CrossRefPubMedGoogle Scholar
  14. 14.
    Moses, RA, Adlers Physiology of the Eye, Seventh edition, CV Mosby Co Chapt 1. P1Google Scholar
  15. 15.
    Liu J, Sheha H, Tseng SC (2010) Pathogenic role of Demodex mites in blepharitis. Curr Opin Allergy Clin Immunol 10(5):505–510CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Li J, O’Reilly N, Sheha H et al (2010) Correlation between ocular Demodex infestation and serum immunoreactivity to bacillus proteins in patients with facial rosacea. Ophthalmology 117(5):870–877CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Forton FM (2012) Papulopustular rosacea, skin immunity and Demodex: pityriasis folliculorum as a missing link. J Eur Acad Dermatol Venereol 26(1):19–28CrossRefPubMedGoogle Scholar
  18. 18.
    Georgala S, Katoulis AC, Kylafis GD et al (2001) Increased density of Demodex folliculorum and evidence of delayed hypersensitivity reaction in subjects with papulopustular rosacea. J Eur Acad Dermatol Venereol 15(5):441–444CrossRefPubMedGoogle Scholar
  19. 19.
    Del Rosso JQ (2006) Update on rosacea pathogenesis and correlation with medical therapeutic agents. Cutis 78:97–100PubMedGoogle Scholar
  20. 20.
    Bonamigo RR, Bakos L, Edelweiss M et al (2005) Could matrix metalloproteinase-9 be a link between Demodex folliculorum and rosacea?. J Eur Acad Dermatol Venereol 19:646–647CrossRefPubMedGoogle Scholar
  21. 21.
    Singh SK, Dimri U (2014) The immune: pathological conversions of canine Demodicosis. Vet Parasitol 203(1–2):1–5CrossRefPubMedGoogle Scholar
  22. 22.
    Mumcuoglu KY, Akilov OE (2005) The role of HLA A2 and Cw2 in the pathogenesis of human Demodicosis. Dermatology 210(2):109–114CrossRefPubMedGoogle Scholar
  23. 23.
    Zhao YE, Hu L, Wu LP et al (2012) A meta: analysis of association between acne vulgaris and Demodex infestation. J Zhejiang Univ Sci 13(3):192–202CrossRefGoogle Scholar
  24. 24.
    Rawal M, Tiliakos A, Hostoffer RW (2004) Demodicosis: an unusual presentation of small lymphocytic lymphoma. J Allergy Clin Immunol 113(2):S121CrossRefGoogle Scholar
  25. 25.
    Wiwanitkit S, Wiwanitkit V (2013) Prevalence of Eyelash Demodex among Human Immunodeficiency Virus Infected Patients at Different CD4+ Count Status. Int J Trichology 5(3):166CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Karincaoglu Y, Esrefoglu Seyhan M, Bayram N et al (2005) Incidence of Demodex folliculorum in patients with end stage chronic renal failure. Ren Fail 27(5):495–499CrossRefPubMedGoogle Scholar
  27. 27.
    Geerlings SE, Hoepelman AL (1999) Immune dysfunction in patients with diabetes mellitus (DM). Immunol Med Microbiol 26(3–4):259–265CrossRefGoogle Scholar
  28. 28.
    Chinen J, Ram G (2011) Infections and immunodeficiency in Down Syndrome. Clin Exp Immunol 164(1):9–16CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Cullen JF (1963) Communications Mongolism (Down’s Syndrome) and Keratoconus. Brit J Ophthal 47:321CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Montecino-Rodriguez E, Berent-Maoz B, Dorshkind K (2013) Causes, consequences, and reversal of immune system aging. J Clin Invest 123(3):958–965CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Aw D, Silva AB, Palmer DB (2007) Immunosenescence: emerging challenges for an ageing population. Immunology 120:435–446CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Aranow C (2011) Vitamin D and the Immune System. J Investig Med 59(6):891–896CrossRefGoogle Scholar
  33. 33.
    Besedovsky L, Lange T, Born J (2012) Sleep and immune function. Pflugers Arch 463(1):121–137CrossRefPubMedGoogle Scholar
  34. 34.
    Segerstrom S, Miller GE (2004) Psychological Stress and the Human Immune System: a meta analytic study of 30 years of inquiry. Psychol Bull 130(4):601–630CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Banerjee BD, Koner BC, Ray A (1996) Immunotoxicity of pesticides: perspectives and trends. Indian J Exp Biol 34(8):723–733PubMedGoogle Scholar
  36. 36.
    Kharrizian D (2014) The potential roles of bisphenol A (BPA) pathogenesis in autoimmunity. Autoimmune Dis. doi: 10.1155/2014/743616 Google Scholar
  37. 37.
    Cressey D (2012) Manufacturing chemicals may damage the immune system. Nature, http://www.nature.com/news/manufacturing-chemicals-may-damage-the-immune-system-1.9877. Accessed July 2015
  38. 38.
    Han SN, Leka LS, Lichtenstein AH et al (2002) Effect of hydrogenated and saturated, relative to polyunsaturated fat on immune and inflammatory responses of adults with moderate hypercholesterolemia. J Lipid Res 43(3):445–452PubMedGoogle Scholar
  39. 39.
    McMurray DN (1984) Cell: mediated immunity in nutritional deficiency. Prog Food Nutri Sci 8(3–4):193–228Google Scholar
  40. 40.
    Bender AE (1976) Subclinical and covert malnutrition. Bull Schweiz Akad Med Wiss 31(4):279–290PubMedGoogle Scholar
  41. 41.
    Watson C (2003) Human infestation with bird mites in Wollongong. Commun Dis Intell 27(2):259–261Google Scholar
  42. 42.
    Da Silva CA, Chalouni C, Williams A et al (2015) Chitin is a size-dependent regulator of macrophage TNF and IL-10 production. J Immunol 195(6):3573–3582Google Scholar
  43. 43.
    Nicholls SG, Oakley CL, Tan A, Vote BJ (2016) Demodex treatment in external ocular disease: the outcomes of a Tasmanian case series. Int ophthalmol. doi: 10.1007/s10792-016-0188-5
  44. 44.
    Rodriguez AE, Ferrer C, Alio JL (2005) Chronic blepharitis and Demodex. Arch Soc Esp Oftalmol 80(11):635–642CrossRefPubMedGoogle Scholar
  45. 45.
    Gao Y-Y, Di Pascuale MA, Li W et al (2005) In vitro and in vivo killing of ocular demodex by tea tree oil. Br J Ophthalmol 89(11):1468–1473CrossRefPubMedPubMedCentralGoogle Scholar
  46. 46.
    Tighe S, Goa YY, Tseng SCG (2013) Terpinen-4-ol is the most active ingredient of tea tree oil to kill Demodex mites. Transl Vis Sci 2(7):2CrossRefGoogle Scholar
  47. 47.
    Larson D (2012) Tea: tree oil is not without its complications. Dermatitis 1:48–49CrossRefGoogle Scholar
  48. 48.
    Mozelsio NB, Harris KE, McGrath KG et al (2003) Immediate systemic hypersensitivity reaction associated with topical application of Australian tea tree oil. Allergy Asthma Proc 24(1):73–75PubMedGoogle Scholar
  49. 49.
    Holzchuh FG, Hida RY, Moscovici BK et al (2011) Clinical treatment of ocular Demodex folliculorum by systemic ivermectin. Am J Ophthalmol 151(6):1030–1034CrossRefPubMedGoogle Scholar
  50. 50.
    Salem DA, El-Shazly A, Nabih N et al (2013) Evaluation of the efficacy of oral ivermectin in comparison with ivermectin: metronidazole combined therapy in the treatment of ocular and skin lesions of Demodex folliculorum. Int J Infect Dis 17(5):343–347CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2016

Authors and Affiliations

  • Stephen G. Nicholls
    • 1
    • 2
  • Carmen L. Oakley
    • 3
    • 4
    Email author
  • Andrea Tan
    • 3
  • Brendan J. Vote
    • 3
  1. 1.Tasmanian Eye ClinicsGlenorchyAustralia
  2. 2.Menzies Research InstituteHobartAustralia
  3. 3.Tasmanian Eye InstituteSouth LauncestonAustralia
  4. 4.Save Sight InstituteUniversity of SydneySydneyAustralia

Personalised recommendations